Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neogenomics Inc (NQ: NEO )

18.16 +0.05 (+0.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 760,771
Open 18.25
Bid (Size) 18.16 (1)
Ask (Size) 19.25 (1)
Prev. Close 18.11
Today's Range 17.97 - 18.86
52wk Range 6.000 - 19.51
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
From Massive Bio, Inc.
Via Business Wire
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
The high-flyers have soared to new heights and further gains could be up ahead. 
Via The Motley Fool

Performance

YTD
+99.78%
+99.78%
1 Month
+38.10%
+38.10%
3 Month
+90.56%
+90.56%
6 Month
+101.33%
+101.33%
1 Year
+3.89%
+3.89%

More News

Read More
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
Via ACCESSWIRE
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
Via ACCESSWIRE
Analyst Ratings for NeoGenomics
Via Benzinga
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
Via Benzinga
Why Shares of NeoGenomics Jumped Today
Via The Motley Fool
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher
Via Benzinga
Why NeoGenomics Shares Are Trading Higher Today
Via Benzinga
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
Via ACCESSWIRE
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US Stocks Turn Lower; Dow Drops 150 Points
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023
Via SBWire
Earnings Scheduled For February 23, 2023
Via Benzinga
NEO FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023
Via ACCESSWIRE
RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery
Via ACCESSWIRE
NEO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
From Kahn Swick & Foti, LLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.